Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents

A new series of 3,5-bis(arylidene)-4-piperidones, as chalcone analogues carrying variety of aryl and heteroaryl groups, pyrazolo[4,3-c]pyridines, pyrido[4,3-d]pyrimidines, and pyrido[3,2-c]pyridines, carrying an arylidene moiety, and a series of pyrano[3,2-c]pyridines, as flavone and coumarin isosteres, were synthesized and screened for their in vitro antiviral and antitumor activities at the National Cancer Institute (NCI). Compounds 9 and 18 proved to be active against herpes simplex virus-1 (HSV-1), while compound 13 showed moderate activity against human immunodeficiency virus-1 (HIV-1). Compounds 14, 26, 28, 33, and 35 exhibited a broad spectrum antitumor activity. In addition, compounds 26, 33, and 35 proved to be of moderate selectivity toward leukemia cell lines. The pyrano[3,2-c]pyridines heterocyclic system proved to be the most active antitumors among the investigated heterocycles.

[1]  A. Khodair,et al.  Synthesis of certain 5-substituted 2-thiohydantoin derivatives as potential cytotoxic and antiviral agents. , 1997, Bollettino chimico farmaceutico.

[2]  M. Boyd,et al.  Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .

[3]  C. Yit,et al.  Cytotoxic effect of butein on human colon adenocarcinoma cell proliferation. , 1994, Cancer letters.

[4]  E. Pedersen,et al.  S-glucosylated hydantoins as new antiviral agents. , 1994, Journal of medicinal chemistry.

[5]  M. Boyd,et al.  Two new cytotoxic chalcones from Calythropsis aurea. , 1993, Journal of natural products.

[6]  N. Das,et al.  In vitro effects of natural plant polyphenols on the proliferation of normal and abnormal human lymphocytes and their secretions of interleukin-2. , 1993, Cancer letters.

[7]  M R Grever,et al.  The National Cancer Institute: cancer drug discovery and development program. , 1992, Seminars in oncology.

[8]  R. Pardini,et al.  Inhibition of glutathione reductase by flavonoids. A structure-activity study. , 1992, Biochemical pharmacology.

[9]  U. R. Kuppusamy,et al.  Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. , 1992, Biochemical pharmacology.

[10]  M. Duffy,et al.  Evaluation of some N-acyl analogues of 3,5-bis(arylidene)-4-piperidones for cytotoxic activity. , 1992, Drug design and discovery.

[11]  R. Rogers,et al.  Preparation, characterization, and antiviral activity of microbial metabolites of stemodin. , 1991, Journal of natural products.

[12]  H. Newmark.  Plant phenolics as inhibitors of mutational and precarcinogenic events. , 1987, Canadian journal of physiology and pharmacology.

[13]  J. Dimmock,et al.  ANTILEUKEMIC EVALUATION OF SOME MANNICH BASES DERIVED FROM 2-ARYLIDENE-1,3-DIKETONES , 1983 .

[14]  D. Pilbeam.  The Flavonoids: Advances in Research : Edited by J.B. Harborne and T.J. Mabry Chapman and Hall; London, New York, 1982 744 pages. £ 49.50 , 1983 .

[15]  E. Racker,et al.  The effect of flavonoids on aerobic glycolysis and growth of tumor cells. , 1975, Cancer research.

[16]  W. Haenszel,et al.  A case-control study of large bowel cancer in Japan. , 1980, Journal of the National Cancer Institute.